Deep-red to NIR Solution-Processed OLEDs of Donor-Decorated Quinoxaline-based TADF Aggregates

11 December 2024, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

We report the use of an extended -conjugated electron-deficient “pyrazino[2,3-g]quinoxaline (PQ)” as a strong, planar acceptor in a donor-acceptor thermally activated delayed fluorescence emitter design to achieve deep-red to NIR emission. A pair of multi-donor-acceptor (multi-D-A) emitters, 4DMAC-TPPQ and 4PXZ-TPPQ, using PQ as the strong acceptor and dimethylacridine (DMAC) and phenoxazine (PXZ) as strong donors, respectively, emit at 650 and 762 nm in toluene, which is significantly red-shifted in comparison to the parent compound TPPQ (PL = 456 nm). Both compounds show aggregation-induced emission enhancement in THF:water mixtures. Both compounds are TADF as doped films in 4,4′-bis(N-carbazolyl)-1,1′-biphenyl (CBP) and as neat films. The emission of the neat film is similar to that in toluene with PL of 654 and 770 nm for 4DMAC-TPPQ and 4PXZ-TPPQ, respectively. Solution-processed organic light-emitting diodes (SP-OLEDs) of neat 4DMAC-TPPQ showed electroluminescence (EL) at 685 nm and EQEmax of 0.3%, while the device with 4PXZ-TPPQ emitted at EL of 780 nm and showed an EQEmax of 0.04%. The OLEDs with 4PXZ-TPPQ showed the most red-shifted emission amongst those employing TADF emitters containing a quinoxaline-type acceptor.

Keywords

AIE
Pyrazine Quinoxaline
Near infrared
Thermally activated delayed fluorescence
Organic light-emitting diodes

Supplementary materials

Title
Description
Actions
Title
ESI
Description
Electronic Supporting Information
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.